East Brunswick, NJ, United States of America

John D DiMarco

USPTO Granted Patents = 16 

 


Average Co-Inventor Count = 6.1

ph-index = 7

Forward Citations = 187(Granted Patents)


Location History:

  • East Brunswick, NJ (US) (2002 - 2014)
  • Princeton, NJ (US) (2012 - 2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Innovations and Contributions of John D. DiMarco in Pharmaceutical Sciences

Introduction

John D. DiMarco, an innovative inventor based in East Brunswick, NJ, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 16 patents, he has dedicated his career to developing novel therapies that address critical health issues, particularly diabetes.

Latest Patents

Among his most recent innovations are the patents related to crystal structures of SGLT2 inhibitors. This patent outlines the preparation of physical crystal structures of compounds designed to treat diabetes. Another notable patent focused on the crystal forms of saxagliptin, detailing various forms, including monohydrates and hydrochloric acid salts. These innovative forms are crucial for enhancing the effectiveness of pharmaceutical compositions aimed at managing diabetes.

Career Highlights

John D. DiMarco has had a distinguished career, working with leading pharmaceutical companies. Notably, he has been associated with Bristol-Myers Squibb Company and AstraZeneca AB, where he further honed his expertise in drug development and patent innovation. His contributions are not only confined to inventions but also extend to improving existing treatment methodologies in the pharmaceutical industry.

Collaborations

Throughout his career, DiMarco has collaborated with notable figures in the field, including Jack Z. Gougoutas and Michael A. Galella. These partnerships have fostered an environment of innovation and creativity, leading to the successful development of vital therapeutic solutions.

Conclusion

John D. DiMarco stands out as a prolific inventor whose work continues to influence the pharmaceutical landscape. His patents on SGLT2 inhibitors and saxagliptin crystal forms play a critical role in advancing diabetes treatment. With his extensive experience and successful collaborations, DiMarco is a valuable asset to the innovation community in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…